HCPLive

JANUARY 16, 2025

In this episode, hosts explore ADA's evolving guidelines championing broader access to CGM and AID systems for personalized diabetes care.

Diabetes 64

Diabetes Technology 64

DAIC

FEBRUARY 26, 2025

tim.hodson Wed, 02/26/2025 - 10:24 Feb. 25, 2025 Heartflow, Inc. , a provider of AI technology for coronary artery disease (CAD) management, recently introduced its new brand identity reflecting its focus on delivering clarity, precision and confidence in the prevention, diagnosisand treatment of CAD. In the U.S.,

Coronary Artery Disease 59

Coronary Artery Disease Heart attacks Heart Attack Technology 59

DAIC

MARCH 28, 2025

tim.hodson Fri, 03/28/2025 - 15:23 Mar. v As cardiovascular disease (CVD) continues to rise globally, vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. Our introduction of Revolution Vibe underscores our commitment to this mission.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

DAIC

APRIL 4, 2025

Source: Tower Health tim.hodson Fri, 04/04/2025 - 10:03 April 3, 2025 Tower Health and Siemens Healthineers recently announced a 10-year agreementfocused on equipment enhancement, technology modernization and improving clinical experience for patients. Reading Hospital, part of the Tower Health healthcare system.

Patient Care 52

Patient Care Technology Innovation Cardiovascular Imaging 52

HCPLive

MARCH 3, 2025

In this episode, hosts discuss the implications of recent changes in GLP-1 RA availability as well as diabetes technology updates.

Diabetes 72

Diabetes Technology 72

DAIC

JANUARY 7, 2025

tim.hodson Tue, 01/07/2025 - 10:01 Jan. 7, 2025 FIRE1 recently announced it has received Breakthrough Device Designation from the U.S. The company also announced Ellie McGuire, Partner at Polaris Partners, and Michael Wasserman, Partner and COO at Elevage Medical Technologies have joined its Board of Directors.

Heart Failure 64

Heart Failure Chronic Disease Innovation Technology 64

International Journal of Cardiovascular Sciences

MARCH 27, 2025

The International Journal of Cardiovascular Sciences has extended the deadline for article submissions to the special issue on Artificial Intelligence in Cardiovascular Health until August 30, 2025 ! Publications in this collection will continue until December 2025. Erito Marques de Souza Filho and Roberto Botelho.

Article 52

Article Innovation Education Research 52

American College of Cardiology

JANUARY 6, 2025

As the new year begins, the landscape of cardiovascular medicine is undergoing a remarkable transformation, driven by groundbreaking technologies and innovative approaches that promise to revolutionize patient care.

Innovation 66

Innovation Technology Patient Care Article 66

DAIC

FEBRUARY 12, 2025

tim.hodson Wed, 02/12/2025 - 15:04 Feb. 12, 2025 On Feb. 11, 2025, at HonorHealth Research Institute, Rahul Doshi, M.D., Through clinical trials, we remain committed to advancing cutting edge technology and innovative therapy to improve patient care." among the clinical trials 32 sites nationwide.

AFIB 52

AFIB Research Ablation Atrial Fibrillation 52

DAIC

FEBRUARY 14, 2025

tim.hodson Fri, 02/14/2025 - 14:32 Feb. tim.hodson Fri, 02/14/2025 - 14:32 Feb. The presentation,"Effects of Atrioventricular Interval Modulation (AVIM) Therapy in Subjects with Hypertension and Diastolic Dysfunction,"was deliveredby Marat Fudim, M.D., Advanced Heart Failure Cardiologist, Duke Health on Feb.

Blood Pressure 52

Blood Pressure Heart Failure Hypertension Technology 52

DAIC

JULY 18, 2024

In accordance with the AMA semi-annual early release schedule, the new codes will be effective January 1st, 2025 and published in the 2025 CPT Code book. CPT codes are widely used by government payers, including Medicare and Medicaid, and commercial insurance companies to identify healthcare services and procedures for reimbursement.

Reimbursement 105

Reimbursement Electrocardiogram Technology Medicaid 105

HCPLive

APRIL 4, 2025

In the first of 2 episodes spotlighting the meeting, hosts break down news and updates from the Advanced Technologies and Treatments for Diabetes meeting.

Diabetes 52

Diabetes Technology 52

CardiacWire

APRIL 2, 2025

The ACC 2025 meeting is all wrapped up after matching the attendance and excitement of last years expo, with a clear trend toward better diagnostics and even better pharmaceuticals. Among dozens of highlights, here are Cardiac Wires seven biggest trends from ACC.25. Diverse Pharma ACC.25 The post The Top Trends of ACC.25

Reimbursement 64

Reimbursement TAVR Research Innovation 64

DAIC

FEBRUARY 10, 2025

tim.hodson Mon, 02/10/2025 - 12:43 Feb. 6, 2025 Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung diseases, recently announcedpublication of a peer-reviewed study evaluating its novel algorithm for the detection of pulmonary hypertension (PH).

Research 64

Research Innovation Pulmonary Hypertension 64

DAIC

JANUARY 30, 2025

tim.hodson Thu, 01/30/2025 - 15:12 Penumbra recently launched its Element Vascular Access System , a laser-cut hypotube sheath designed for venous thromboembolism (VTE). Innovative Valve Technology Element features the HemoLockValve System, designed to ensure hemostasis through dual-valve engineering. CAT TM 16 catheter.

Technology 52

Technology Anatomy Embolism Innovation 52

DAIC

MARCH 27, 2025

tim.hodson Thu, 03/27/2025 - 12:18 March 27, 2025 Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib). The company will further expand use of Volt in EU markets throughout the second half of 2025. AF Symposium 2025,Boston MA, USA.

Ablation 52

Ablation AFIB Atrial Fibrillation Electrophysiology 52

DAIC

JULY 29, 2024

Edwards has entered into an agreement to acquire JenaValve Technology , a pioneer in the transcatheter treatment of aortic regurgitation (AR), a deadly disease that impacts a significant and growing population and is largely untreated today. A CMS national coverage determination is expected in early 2025. billion.

Innovation 105

Innovation Aortic valve Aortic CMS 105

DAIC

MARCH 24, 2025

tim.hodson Mon, 03/24/2025 - 15:48 March 24, 2025 Imperative Care, Inc. Historically, peripheral vascular thrombectomy has lacked technologies that effectively address challenging clot and preserve vessel health for the patient, said Doug Boyd, SVP and General Manager of Imperative Cares Vascular business.

Blood Clot 52

Blood Clot Vascular Care Technology Thrombosis 52

DAIC

MARCH 11, 2025

tim.hodson Tue, 03/11/2025 - 10:25 March 11, 2025 Caristo Diagnosticshas received U.S. Food and Drug Administration (FDA) 510(k) clearance of its CaRi-Plaquetechnology, an AI-assisted image analysis application to aid the diagnosis of coronary artery disease (CAD).

Plaque 52

Plaque Heart attacks Heart Attack Technology 52

DAIC

FEBRUARY 14, 2025

tim.hodson Fri, 02/14/2025 - 09:57 Feb. Despite advances in catheter ablation technology, persistent AF remains one of the most challenging subtypes of atrial fibrillation to treat, affecting over 70% of all patients with atrial fibrillation globally.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Technology Pulmonary 52

DAIC

FEBRUARY 18, 2025

tim.hodson Tue, 02/18/2025 - 16:17 Feb. 11, 2025 UltraSight, a company committed to enhancing the efficiency and productivity of cardiac ultrasound,recentlyannounced support from Bristol Myers Squibb (BMS) for a study that aims to improve access to echocardiographic assessments for patients with obstructive hypertrophic cardiomyopathy (oHCM).

Ultrasound 52

Ultrasound Echocardiogram Innovation Cardiomyopathy 52

Cardiometabolic Health Congress

OCTOBER 10, 2024

This exciting overview highlights the top 10 AI-powered cardiometabolic startups poised to make significant impacts in 2025. From chatbots providing 24/7 support to AI-powered health coaches offering personalized lifestyle recommendations, these technologies will be crucial in chronic disease management.

Innovation 52

Innovation Technology Kidney Disease Chronic Disease 52

Society of Thoracic Surgeons - Early Career

JANUARY 20, 2025

STS's 61st Annual Meeting in Los Angeles brings together cardiothoracic surgeons from around the world and features late-breaking scientific research, cutting-edge technologies, and meaningful networking opportunities.

Cardiothoracic 52

Cardiothoracic Technology Research 52

DAIC

APRIL 8, 2025

David Luria (left), Director of Electrophysiology at Hadassah Medical Center, and Ziv Menshes (right), CEO of CardioVia tim.hodson Tue, 04/08/2025 - 14:38 April 7, 2025 CardioVia, a medical device company specializing in advanced cardiac care solutions, has received U.S.

Electrophysiology 52

Electrophysiology Arrhythmia Innovation Technology 52

DAIC

JULY 15, 2024

Combined with Edwards’ existing mitral innovations, the acquisition enhances the company’s TMVR technologies to address large unmet structural heart patient needs and support sustainable long-term growth. Edwards’ SAPIEN M3 remains on track to become the first approved transfemoral TMVR system in Europe by the end of 2025.

Bicuspid/Mitral 105

Bicuspid/Mitral Tricuspid Technology Innovation 105

DAIC

JANUARY 28, 2025

Faubert and Shang Wang, Stevens Institute of Technology tim.hodson Tue, 01/28/2025 - 10:45 Jan. 2025 Researchers have developed a new software tool that provides unprecedented capabilities to see inside 3D images. Credit : Andre C.

Research 52

Research Congenital Technology Congenital Heart Disease 52

DAIC

JANUARY 8, 2025

tim.hodson Wed, 01/08/2025 - 14:11 Jan. 8, 2025 Mineralys Therapeutics, Inc., The Company anticipates initiating the trial in the first quarter of 2025. a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases, hasannounced that the U.S.

Blood Pressure 52

Blood Pressure Hypertension Kidney Disease BMI 52

DAIC

MARCH 31, 2025

tim.hodson Mon, 03/31/2025 - 15:02 March 31, 2025 iRhythm Technologies, Inc. has announced results from two large real-world retrospective analyses presented at the American College of Cardiology (ACC) 2025 Scientific Sessions in Chicago. iRhythm Technologies, 2025. iRhythm Technologies, 2024.

Arrhythmia 52

Arrhythmia Atrial Fibrillation Tachycardia Heart Failure 52

DAIC

JANUARY 6, 2025

tim.hodson Mon, 01/06/2025 - 16:04 Jan. The Harmony TPV system has already been implanted in more than 2,200 patients and now has access to help many more patients across the European Union.

Pulmonary 52

Pulmonary Congenital Heart Disease Open-Heart Surgery Congenital 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ADP10-ADP10, February 1, 2025. We sought to create a learning environment that is more engaging and interactive, utilizing newer educational technologies.Methods:We investigated educational technologies developed for the K-12 educational space. Nurses received immediate feedback.

Education 40

Education Nursing Technology Stroke 40

The American Journal of Cardiology

APRIL 4, 2025

Publication date: Available online 3 April 2025 Source: The American Journal of Cardiology Author(s): Fortunato Iacovelli, Alessandro Cafaro, Antonio Pignatelli, Osvaldo Burattini, Francesco Spione, Luigi Salemme, Angelo Cioppa, Armando Pucciarelli, Grigore Popusoi, Eugenio Stabile, Tullio Tesorio

Aortic valve 40

Aortic valve Technology Aortic 40

DAIC

MARCH 27, 2025

tim.hodson Thu, 03/27/2025 - 15:40 March 27, 2025 GE HealthCare is announcing theU.S.launch of Flyrcado(flurpiridaz F 18) injection at the 2025American College of Cardiology(ACC) AnnualScientific Session & Expo inChicago. Flyrcado is aunit dose positron emission tomography myocardial perfusion imaging (PET MPI) agent.

Coronary Artery Disease 52

Coronary Artery Disease CMS Innovation Ischemia 52

Becker's Hospital Review - Cardiology

FEBRUARY 13, 2025

Technology company Merative's Merge Cardio was named the 2025 Best in KLAS winner for cardiology and the 2025 Best in KLAS winner for hemodynamics among vendors offering health information technology solutions, according to a Feb. 12 report from KLAS Research.

Technology 52

Technology Research 52

DAIC

NOVEMBER 8, 2024

It becomes effective January 1, 2025, and is expected to remain effective for up to three years. In approving the TPT, CMS created a distinct device category and code (C1736: Catheter Renal Denervation, Ultrasound) for Ultrasound Renal Denervation in recognition of the differentiated technology and procedure with the Paradise uRDN System. “The

CMS 40

CMS Ultrasound Blood Pressure Reimbursement 40

DAIC

JANUARY 29, 2025

tim.hodson Wed, 01/29/2025 - 13:02 Jan. The results were presented at the AF Symposium 2025. By 2030, approximately 12.2 million people in the U.S. will have AF, an irregular and potentially dangerous heart rhythm.

AFIB 52

AFIB Atrial Fibrillation Quality of Life Heart Rhythm 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP142-AWP142, February 1, 2025. Consequently, hyperacute antihypertensive therapy could potentially aid prehospital patients identified as likely having ICH by clinical scales and helmet technologies.

Technology 40

Technology Hemorrhage Blood Pressure Ischemia 40

DAIC

APRIL 5, 2024

Shockwave is a leading, first-to-market provider of innovative intravascular lithotripsy (IVL) technology for the treatment of calcified CAD and PAD. Shockwave offers the only commercially available IVL technology and has safely, simply, and effectively treated approximately 400,000 patients globally.

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105